| Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures |
| | | | | | | | | | | | | | | | Period ended May 30, | | Years ended December 31, | | | 2014 | | 2013 | | 2012 | Discontinued Operations (in thousands) | | | | | | | Revenue: | | | | | | | Bioscience product sales and services | | $ | 12,470 |
| | $ | 42,870 |
| | $ | 43,240 |
| Cost of revenue: | | | | | | | Cost of bioscience product sales and services | | 4,235 |
| | 15,436 |
| | 15,025 |
| Gross margin | | 8,235 |
| | 27,434 |
| | 28,215 |
| Operating expenses: | | | | | | | Selling and marketing | | 6,237 |
| | 13,772 |
| | 14,792 |
| Research and development | | 2,248 |
| | 7,797 |
| | 10,283 |
| General and administrative | | 643 |
| | 1,621 |
| | 1,308 |
| Restructuring costs | | 19 |
| | 284 |
| | — |
| Total operating expenses | | 9,147 |
| | 23,474 |
| | 26,383 |
| Earnings (loss) from discontinued operations | | (912 | ) | | 3,960 |
| | 1,832 |
| Other income (expense), net | | 81 |
| | (145 | ) | | (1,155 | ) | Earnings (loss) from discontinued operations before income taxes | | (831 | ) | | 3,815 |
| | 677 |
| Income tax benefit (expense) | | 248 |
| | (1,654 | ) | | (415 | ) | Gain on sale of discontinued operations, net of tax | | 15,959 |
| | — |
| | — |
| Earnings from discontinued operations | | $ | 15,376 |
| | $ | 2,161 |
| | $ | 262 |
| | | | | | | |
The following table summarizes the assets and liabilities of discontinued operations as of December 31, 2013 related to the Bioscience business segment (in thousands): | | | | | | December 31,
2013 | Assets | | Current assets: | | Accounts receivable, net | $ | 7,696 |
| Inventories | 5,370 |
| Other current assets and prepaid expenses | 408 |
| Total current assets | 13,474 |
| Property, equipment and leasehold improvements, net | 2,175 |
| Other assets | 133 |
| Total noncurrent assets | 2,308 |
| Total assets of discontinued operations | $ | 15,782 |
| | | Liabilities and stockholders' equity | | Current liabilities: | | Accounts payable | $ | 868 |
| Accrued expenses | 2,878 |
| Other current liabilities | 2,461 |
| Total current liabilities of discontinued operations | 6,207 |
| Other long-term liabilities | 946 |
| Cumulative translation adjustment | 527 |
| Total liabilities and equity of discontinued operations | $ | 7,680 |
|
|